SRSA
IBB icon

S.R. Schill & Associates’s iShares Biotechnology ETF IBB Stock Holding History

S.R. Schill & Associates’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,995
Closed -$222K – 71
2017
Q3 		$222K Buy
1,995
+15
+0.8% +$1.6K 0.13% 68
2017
Q2 		$205K Sell
1,980
-20,709
-91% -$2.04M 0.13% 70
2017
Q1 		$2.22M Sell
22,689
-72
-0.3% -$6.89K 1.41% 18
2016
Q4 		$2.01M Sell
22,761
-3,771
-14% -$343K 1.31% 18
2016
Q3 		$2.56M Buy
+26,532
New +$2.52M 1.68% 14

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

S.R. Schill & Associates's IBB Position: Q4 2017 in Review

S.R. Schill & Associates sold out of iShares Biotechnology ETF (IBB) in Q4 2017, closing a stake of 1,995 shares — an estimated $222K sold.

S.R. Schill & Associates first reported a position in IBB in Q3 2016 and held it in 5 quarters. The position peaked at $2.56M in Q3 2016. 624 funds tracked by Wall St. Rank hold IBB as of Q4 2017.

  • S.R. Schill & Associates reported no remaining iShares Biotechnology ETF position as of Q4 2017 after selling out during the quarter.
  • S.R. Schill & Associates sold 1,995 iShares Biotechnology ETF shares in Q4 2017, an estimated $222K.
  • S.R. Schill & Associates first reported a position in iShares Biotechnology ETF in Q3 2016 and held it in 5 quarters.
  • S.R. Schill & Associates's iShares Biotechnology ETF position peaked at $2.56M in Q3 2016.
  • 624 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2017.

Based on S.R. Schill & Associates's 13F filing for Q4 2017, filed 5 Feb 2018.